Clinical Trials Directory

Trials / Completed

CompletedNCT07355530

Can Adipose Derived Regenrative Cells be Used for Treating Erectile Dysfunction After Radical Prostatectomy

A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected Into Corpora Cavernosum Following Radical Prostatectomy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Odense University Hospital · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The goal of this study was to investigate if adipose derived regenerative cells can be used as a treatment for erectile dysfunction following radical prostatectomy. 70 participants were enrolled in the study and was performed as a double- blinded study. 35 participants in the active study arm recieved an injection into the penis of adipose derived regenerative cells, while the participants of the placebo arm recieved a placebo injection. All 70 participants undervent liposuccion of the abdomen to harvest the adipose derived regenerative cells, and the 35 participants in the active study arm recieved their own regenerative cells. All participants answered the questionnaires International-Index-of- Erectile function 5 and Erection Hardness Scale before treatment and after 1,3,6 and 12 months. These data was used to evaluate the effect of one injection of adipose derived regenerative cells.

Conditions

Interventions

TypeNameDescription
DRUGAdipose-Derived Regenerative CellsAdipose-derived regenerative cells was injected into the corpus cavernosum.
OTHERPlaceboInjection of ringer lactate

Timeline

Start date
2018-01-20
Primary completion
2021-03-03
Completion
2021-03-03
First posted
2026-01-21
Last updated
2026-01-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07355530. Inclusion in this directory is not an endorsement.